Archive for April 2017
Diagnostic Accuracy of a Host Gene Expression Signature That Discriminates Clinical Severe Sepsis Syndrome and Infection-Negative Systemic Inflammation Among Critically Ill Children
Zimmerman et al., Critical Care Medicine | SeptiCyte Lab is able to discriminate clearly between clinically well-defined and homogeneous postcardiopulmonary bypass and clinically overt severe sepsis syndrome groups in children. A broader investigation among children with more heterogeneous inflammation-associated diagnoses and care settings is warranted.
Read MoreEuropean Molecular Diagnostics 2017
Molecular Diagnostics Europe 10-13 April 2017 Lisbon, Portugal. Dayle Sampson, Director of Bioinformatics at Immunexpress, presented on the Dynamics of Host Response in Severe Respiratory Illness. He described ongoing work at Immunexpress on using different signatures to understand the contribution of different pathogen classes to sepsis.
Read More